Approval · Notice of Compliance 4883 · 1995
BURINEX: Notice of Compliance 4883
Issued July 19, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4883
- Date
- July 19, 1995
- Company
- Leo Laboratories Canada Ltd.
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength: 2mg
- Therapeutic class
- Diuretic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BURINEX | 02176076 | Cancelled Post Market |
Medicinal ingredients
- BUMETANIDE 2 MG per TAB